Prime Therapeutics launches Specialty Monitor™ to deliver total drug management insights
Industry leading analytics tool maximizes power of both medical, pharmacy benefits data, provides clients actionable savings opportunities as use of specialty drugs grow. Press release
News from Prime
Prime released a statement from Mike Kolar, its senior vice president and general counsel, in response to the Health and Human Services (HHS) Office of Inspector General’s new safe harbor rule proposal to eliminate prescription drug rebates in Medicare Part D.
Rae McMahan addressed critical cost and care challenges for payers and patients.
Sid brings more than 20 years of experience in health care and pharmacy benefits management to Prime.
Prime in the news
Medical Marketing and Media
Managed Healthcare Executive
Backlash against copay accumulators
Managed Care Magazine